Quick hits from the first two days of the Conference. Follow CortJohnson on Twitter tomorrow for more
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
CortJohnson Cort Johnson
IACFS/ME Ottawa – Clauw reports that FM is everywhere! and looks the same everywhere….it looks the same in Kenya as it does in the US
CortJohnson Cort Johnson
IACFS/ME Ottawa – Clauw believes in the next 10-20 years, medical est. will get that CFS/FM conditions are most expensive/ prevalent of all
CortJohnson Cort Johnson
IACFS/ME Ottawa – Clauw believes an FM/CFS like-condition occurs in 20-30% of ALL disorders…20-30% of arthritis, cancer,,patients have it
CortJohnson Cort Johnson
CortJohnson Cort Johnson
IACFS/ME: Montoya suggests NIH convene meeting to create a standardized approach to research protocols for CFS…
CortJohnson Cort Johnson
IACFS/ME Ottawa – Montoya says focus on PBMC’s in studies means CFS researchers are missing important information on TLR’s and others.
CortJohnson Cort Johnson
IACFS/ME Ottawa- Montoya suggests researchers have been looking at the wrong part of the immune system in CFS; should be studying innate sys
CortJohnson Cort Johnson
IACFS/ME Ottawa – Only Ruscetti and WPI find XMRV in BWG study but in different patients and in as many healthy controls as CFS patients.
CortJohnson Cort Johnson
IACFS/ME -BWG group presents devastating results for validity of WPI’s test for XMRV. WPI’s culture test has problems and is not completed.
CortJohnson Cort Johnson
IACFS/ME Ottawa – Mikovits says full genetic sequencing of ‘dozens’ of isolates will take time because of limited resources.